Stocks Some doses of Lilly’s Zepbound will remain in short supply until the end of April, according to the US FDA. From ReutersApril 3, 2024 Risk Disclosure: Trading financial instruments and/or cryptocurrencies involves high risks, including the risk of losing…
Stocks High doses of opioid reversal spray are no better than lower doses in the field, US study finds From ReutersFebruary 8, 2024 (Reuters) – A high-dose version of the opioid withdrawal spray naloxone made by Hikma Pharmaceuticals…
